Source: Dope Magazine
Over the last few years, Israel has put itself firmly on the global map of medicinal cannabis with an established system serving over 20,000 patients, and a healthy approach to research and evidence-based legislation. The emerging scene in Israel has already spawned dozens of new startups eager to carve out a niche, and has seen several valuable contributions to the field.
One innovative young company is Eybna Technologies, which produces plant-derived, strain-specific terpene formulations. I’ve come to check out the scene in Tel Aviv, and hosted by my friends at Eybna, I’m hoping to meet some of the industry’s most important members. I also plan to talk with the people that matter most—the patients themselves—to hear how the system works for them.
How Medicinal Cannabis Works in Israel
The Israeli medicinal cannabis supply system is unique, and consists of eight government-licensed producers serving approximately 23,000 patients. Patients receive a license from the Medical Cannabis Unit of the Ministry of Health, permitting them a specific quantity of medicinal cannabis per month, in the form of flowers, oils, tinctures or capsules.
Patients are charged a flat rate of 370 shekels (around $100) per month—regardless of quantity (which varies immensely, with some patients receiving 10g per month and some receiving 100 or more). For a further 100 shekels ($26), the cannabis will be delivered directly to the patient’s home.
There are just two physical dispensaries in Tel Aviv—one managed by licensed producer, Tikun Olam, and another central dispensary situated in a psychiatric hospital (a fact that some patients are not entirely comfortable with). A third is situated at the Hadassah Hospital in Jerusalem and is operated by the Hebrew University. Patients who are unable or unwilling to collect their prescription in person usually opt for home delivery.
Israel’s Medicinal Cannabis Providers
Please click here to read this article: Medicinal Cannabis In Israel: Patients & Caregivers